Brusatol, an NRF2 inhibitor for future cancer therapeutic

BACKGROUND: Natural products from herbal medicines have long been investigated for their potentials as cancer therapeutics. Besides the development of several herbal medicine-derived anti-cancer agents, such as paclitaxel, vincristine and podophyllotoxin, many recent laboratory findings demonstrated...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Sabrina J., Liu, Yang, Han, Sue, Yang, Chunzhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554866/
https://www.ncbi.nlm.nih.gov/pubmed/31183074
http://dx.doi.org/10.1186/s13578-019-0309-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554866/
https://www.ncbi.nlm.nih.gov/pubmed/31183074
http://dx.doi.org/10.1186/s13578-019-0309-8

Ejemplares similares